Arcellx Inc (ACLX)
87.15
-0.07
(-0.08%)
USD |
NASDAQ |
Nov 21, 16:00
87.15
0.00 (0.00%)
After-Hours: 20:00
Arcellx Debt to Equity Ratio: 0.00 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2023
--
Maximum
Mar 2023
--
Average
--
Median
Mar 2023
Debt to Equity Ratio Benchmarks
| Boston Scientific Corp | 0.5254 |
| AbbVie Inc | 11.78 |
| NovaBay Pharmaceuticals Inc | 0.0476 |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 764.91M |
| Total Liabilities (Quarterly) | 281.89M |
| Shareholders Equity (Quarterly) | 483.02M |
| Current Ratio | 4.286 |